128 related articles for article (PubMed ID: 25084760)
1. Cholesterol 24S-Hydroxylase Overexpression Inhibits the Liver X Receptor (LXR) Pathway by Activating Small Guanosine Triphosphate-Binding Proteins (sGTPases) in Neuronal Cells.
Moutinho M; Nunes MJ; Gomes AQ; Gama MJ; Cedazo-Minguez A; Rodrigues CM; Björkhem I; Rodrigues E
Mol Neurobiol; 2015; 51(3):1489-503. PubMed ID: 25084760
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma.
Han M; Wang S; Yang N; Wang X; Zhao W; Saed HS; Daubon T; Huang B; Chen A; Li G; Miletic H; Thorsen F; Bjerkvig R; Li X; Wang J
EMBO Mol Med; 2020 Jan; 12(1):e10924. PubMed ID: 31777202
[TBL] [Abstract][Full Text] [Related]
3. Effects of Complete and Partial Loss of the 24S-Hydroxycholesterol-Generating Enzyme
Shu HJ; Ziolkowski LH; Salvatore SV; Benz AM; Wozniak DF; Yuede CM; Paul SM; Zorumski CF; Mennerick S
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540675
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain.
Mast N; Charvet C; Pikuleva IA; Stout CD
J Biol Chem; 2010 Oct; 285(41):31783-95. PubMed ID: 20667828
[TBL] [Abstract][Full Text] [Related]
5. Brain cholesterol turnover required for geranylgeraniol production and learning in mice.
Kotti TJ; Ramirez DM; Pfeiffer BE; Huber KM; Russell DW
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3869-74. PubMed ID: 16505352
[TBL] [Abstract][Full Text] [Related]
6. Unbiased insights into the multiplicity of the CYP46A1 brain effects in 5XFAD mice treated with low dose-efavirenz.
Mast N; Butts M; Pikuleva IA
J Lipid Res; 2024 Jun; 65(6):100555. PubMed ID: 38719151
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Glycyrrhiza Polysaccharide on Human Cytochrome P450 46A1 in vitro and in vivo: Implications in Treating Neurological Diseases.
Du J; Chen Z; Chen X; Zhang J; Wang Y; Zhao T; Wang D; Wang C; Chen Y; Meng Q; Sun H; Liu K; Wu J
Curr Drug Metab; 2024 May; ():. PubMed ID: 38797896
[TBL] [Abstract][Full Text] [Related]
8. CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer's disease.
Lerner AJ; Arnold SE; Maxfield E; Koenig A; Toth ME; Fortin B; Mast N; Trombetta BA; Denker J; Pieper AA; Tatsuoka C; Raghupathy S; Pikuleva IA
Alzheimers Res Ther; 2022 Dec; 14(1):198. PubMed ID: 36581878
[TBL] [Abstract][Full Text] [Related]
9. Assessment of cholesterol homeostasis in the living human brain.
Haider A; Zhao C; Wang L; Xiao Z; Rong J; Xia X; Chen Z; Pfister SK; Mast N; Yutuc E; Chen J; Li Y; Shao T; Warnock GI; Dawoud A; Connors TR; Oakley DH; Wei H; Wang J; Zheng Z; Xu H; Davenport AT; Daunais JB; Van RS; Shao Y; Wang Y; Zhang MR; Gebhard C; Pikuleva I; Levey AI; Griffiths WJ; Liang SH
Sci Transl Med; 2022 Oct; 14(665):eadc9967. PubMed ID: 36197966
[TBL] [Abstract][Full Text] [Related]
10. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease.
Djelti F; Braudeau J; Hudry E; Dhenain M; Varin J; Bièche I; Marquer C; Chali F; Ayciriex S; Auzeil N; Alves S; Langui D; Potier MC; Laprevote O; Vidaud M; Duyckaerts C; Miles R; Aubourg P; Cartier N
Brain; 2015 Aug; 138(Pt 8):2383-98. PubMed ID: 26141492
[TBL] [Abstract][Full Text] [Related]
11. The impairment of cholesterol metabolism in Huntington disease.
Leoni V; Caccia C
Biochim Biophys Acta; 2015 Aug; 1851(8):1095-105. PubMed ID: 25596342
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus.
Chali F; Djelti F; Eugene E; Valderrama M; Marquer C; Aubourg P; Duykaerts C; Miles R; Cartier N; Navarro V
Eur J Neurosci; 2015 May; 41(10):1345-55. PubMed ID: 25847620
[TBL] [Abstract][Full Text] [Related]
13. 27-hydroxycholesterol mediates negative effects of dietary cholesterol on cognition in mice.
Heverin M; Maioli S; Pham T; Mateos L; Camporesi E; Ali Z; Winblad B; Cedazo-Minguez A; Björkhem I
Behav Brain Res; 2015 Feb; 278():356-9. PubMed ID: 25453744
[TBL] [Abstract][Full Text] [Related]
14. Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease.
Ahn SB; Jang K; Jun DW; Lee BH; Shin KJ
Dig Dis Sci; 2014 Dec; 59(12):2975-82. PubMed ID: 25102981
[TBL] [Abstract][Full Text] [Related]
15. Hypercholesterolaemia-induced oxidative stress at the blood-brain barrier.
Dias IH; Polidori MC; Griffiths HR
Biochem Soc Trans; 2014 Aug; 42(4):1001-5. PubMed ID: 25109993
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1.
Fond AM; Lee CS; Schulman IG; Kiss RS; Ravichandran KS
J Clin Invest; 2015 Jul; 125(7):2748-58. PubMed ID: 26075824
[TBL] [Abstract][Full Text] [Related]
17. Quantitative detection of free 24S-hydroxycholesterol, and 27-hydroxycholesterol from human serum.
Bandaru VV; Haughey NJ
BMC Neurosci; 2014 Dec; 15():137. PubMed ID: 25539717
[TBL] [Abstract][Full Text] [Related]
18. Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer's disease early phenotypes.
Marquer C; Laine J; Dauphinot L; Hanbouch L; Lemercier-Neuillet C; Pierrot N; Bossers K; Le M; Corlier F; Benstaali C; Saudou F; Thinakaran G; Cartier N; Octave JN; Duyckaerts C; Potier MC
Mol Neurodegener; 2014 Dec; 9():60. PubMed ID: 25524049
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles containing a liver X receptor agonist inhibit inflammation and atherosclerosis.
Zhang XQ; Even-Or O; Xu X; van Rosmalen M; Lim L; Gadde S; Farokhzad OC; Fisher EA
Adv Healthc Mater; 2015 Jan; 4(2):228-36. PubMed ID: 25156796
[TBL] [Abstract][Full Text] [Related]
20. 28-Homobrassinolide: a novel oxysterol transactivating LXR gene expression.
Premalatha R; Srikumar K; Vijayalaksmi D; Kumar GN; Mathur PP
Mol Biol Rep; 2014 Nov; 41(11):7447-61. PubMed ID: 25091941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
